Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
US10787490B2 · kind B2 · utility
13Cited by
34References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 15, 2016 |
| Grant date | Sep 29, 2020 |
| Priority date | — |
| Expiry date | Jul 15, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel diseases, are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.